Achieving Goal Blood Pressure

Area of Science:

• Cardiology
• Pharmacology

Background:

• Current antihypertensive therapy guidelines support both monotherapy and combination treatments.
• Achieving optimal blood pressure (BP) control often necessitates multiple antihypertensive agents.
• Adding a second agent is generally more effective than increasing the dose of a single agent.

Purpose of the Study:

• To evaluate the role and benefits of fixed-dose combinations (FDCs) in antihypertensive therapy.
• To highlight the advantages of FDCs in managing complex hypertension regimens.
• To align with the 2013 European Society of Hypertension (ESH)/European Society of Cardiology (ESC) guidelines.

Main Methods:

• Review of current antihypertensive therapy guidelines, specifically the 2013 ESH/ESC recommendations.
• Analysis of the impact of combination therapy versus dose escalation in BP management.
• Assessment of patient compliance and persistence with single-pill fixed-dose combinations (FDCs).

Main Results:

• Most patients require more than one antihypertensive agent for effective BP control.
• Fixed-dose combinations (FDCs) facilitate the administration of multiple-drug regimens.
• FDCs demonstrate no negative impact on patient compliance or persistence with therapy.
• FDCs have documented beneficial clinical effects in managing hypertension.

Conclusions:

• Fixed-dose combinations (FDCs) are a recommended strategy for antihypertensive therapy according to 2013 ESH/ESC guidelines.
• FDCs simplify treatment regimens, enhance patient adherence, and contribute to improved clinical outcomes.
• The use of FDCs containing two or three agents is supported for achieving adequate BP reduction.